Transgenomic's Q4 Revenues Slide 22 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Transgenomic reported after the close of the market on Thursday a 22 percent drop year over year in fourth quarter revenues.

For the three months ended Dec. 31, 2010, the Omaha, Neb.-based firm reported revenues of $5.1 million, compared to $6.5 million a year ago. In a statement, the firm said that fourth-quarter 2009 figures included an "exceptionally large" order of Wave instruments for the detection of genetic variation.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

HHS Secretary Tom Price says the NIH budget contains unneeded expenses that can be trimmed, Stat News reports.

The chair of the House science committee says the journal Science is not objective, the Huffington Post reports.

In Nature this week: glioma GWAS uncovers new risk loci, and more.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.